메뉴 건너뛰기




Volumn 65, Issue 1, 2013, Pages 30-34

Targeting adenosine receptors with coumarins: Synthesis and binding activities of amide and carbamate derivatives

Author keywords

adenosine receptor ligands; amide derivatives; binding affinity; carbamate derivatives; coumarins

Indexed keywords

3 (ETHYLCARBAMATE) 4 HYDROXYCOUMARIN; 3 (ISOBUTYLCARBAMATE)COUMARIN; 3 AMIDOCOUMARIN DERIVATIVE; 3 CARBAMATECOUMARIN DERIVATIVE; 4 HYDROXY 3 (ISOBUTYLCARBAMATE)COUMARIN; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; AMIDE; CARBAMIC ACID DERIVATIVE; COUMARIN DERIVATIVE; HYDROXYL GROUP; RADIOLIGAND; UNCLASSIFIED DRUG;

EID: 84870870474     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2012.01571.x     Document Type: Article
Times cited : (13)

References (38)
  • 1
    • 15944389028 scopus 로고    scopus 로고
    • Simple coumarins and analogues in medicinal chemistry: Occurrence, synthesis and biological activity
    • Borges F, et al,. Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity. Curr Med Chem 2005; 12: 887-916.
    • (2005) Curr Med Chem , vol.12 , pp. 887-916
    • Borges, F.1
  • 2
    • 84857297856 scopus 로고    scopus 로고
    • Simple coumarins: Privileged scaffolds in medicinal chemistry
    • Borges F, et al,. Simple coumarins: privileged scaffolds in medicinal chemistry. Front Med Chem 2009; 4: 23-85.
    • (2009) Front Med Chem , vol.4 , pp. 23-85
    • Borges, F.1
  • 3
    • 33845933196 scopus 로고    scopus 로고
    • Inhibition of horseradish peroxidase catalytic activity by new 3-phenylcoumarin derivatives: Synthesis and structure-activity relationships
    • Kabeya L, et al,. Inhibition of horseradish peroxidase catalytic activity by new 3-phenylcoumarin derivatives: synthesis and structure-activity relationships. Bioorg Med Chem 2007; 15: 1516-1524.
    • (2007) Bioorg Med Chem , vol.15 , pp. 1516-1524
    • Kabeya, L.1
  • 4
    • 77953134777 scopus 로고    scopus 로고
    • Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: Identification of novel proapoptotic agents
    • Belluti F, et al,. Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: identification of novel proapoptotic agents. Bioorg Med Chem 2010; 18: 3543-3550.
    • (2010) Bioorg Med Chem , vol.18 , pp. 3543-3550
    • Belluti, F.1
  • 5
    • 77954313236 scopus 로고    scopus 로고
    • A novel synthesis of 3-aryl coumarins and evaluation of their antioxidant and lipoxygenase inhibitory activity
    • Roussaki M, et al,. A novel synthesis of 3-aryl coumarins and evaluation of their antioxidant and lipoxygenase inhibitory activity. Bioorg Med Chem Lett 2010; 20: 3889-3892.
    • (2010) Bioorg Med Chem Lett , vol.20 , pp. 3889-3892
    • Roussaki, M.1
  • 6
    • 34948830988 scopus 로고    scopus 로고
    • Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening
    • Ostrov DA, et al,. Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening. Antimicrob Agents Chemother 2007; 51: 3688-3698.
    • (2007) Antimicrob Agents Chemother , vol.51 , pp. 3688-3698
    • Ostrov, D.A.1
  • 7
    • 64349103355 scopus 로고    scopus 로고
    • Structure-activity relationship of new anti-hepatitis C virus agents: Heterobicycle-coumarin conjugates
    • Neyts J, et al,. Structure-activity relationship of new anti-hepatitis C virus agents: heterobicycle-coumarin conjugates. J Med Chem 2009; 52: 1486-1490.
    • (2009) J Med Chem , vol.52 , pp. 1486-1490
    • Neyts, J.1
  • 8
    • 33745941187 scopus 로고    scopus 로고
    • Coumarins as inhibitors of HIV reverse transcriptase
    • Kostova I,. Coumarins as inhibitors of HIV reverse transcriptase. Curr HIV Res 2006; 4: 347-363.
    • (2006) Curr HIV Res , vol.4 , pp. 347-363
    • Kostova, I.1
  • 9
    • 2442507656 scopus 로고    scopus 로고
    • Antibacterial chalcones - Bioisosteric replacement of the 4'-hydroxy group
    • Nielsen SF, et al,. Antibacterial chalcones-bioisosteric replacement of the 4'-hydroxy group. Bioorg Med Chem 2004; 12: 3047-3054.
    • (2004) Bioorg Med Chem , vol.12 , pp. 3047-3054
    • Nielsen, S.F.1
  • 10
    • 71049173711 scopus 로고    scopus 로고
    • Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: Development and biopharmacological profiling of 7-[(3-chlorobenzyl) oxy]-4-[(methylamino)-methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor
    • Pisani L, et al,. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)-methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor. J Med Chem 2009; 52: 6685-6706.
    • (2009) J Med Chem , vol.52 , pp. 6685-6706
    • Pisani, L.1
  • 11
    • 65749116833 scopus 로고    scopus 로고
    • A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors
    • Matos MJ, et al,. A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors. Bioorg Med Chem Lett 2009; 19: 3268-3270.
    • (2009) Bioorg Med Chem Lett , vol.19 , pp. 3268-3270
    • Matos, M.J.1
  • 12
    • 68349155549 scopus 로고    scopus 로고
    • Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors
    • Matos MJ, et al,. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors. Bioorg Med Chem Lett 2009; 19: 5053-5055.
    • (2009) Bioorg Med Chem Lett , vol.19 , pp. 5053-5055
    • Matos, M.J.1
  • 13
    • 77955715784 scopus 로고    scopus 로고
    • Halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors
    • Matos MJ, et al,. Halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors. Bioorg Med Chem Lett 2010; 20: 5157-5160.
    • (2010) Bioorg Med Chem Lett , vol.20 , pp. 5157-5160
    • Matos, M.J.1
  • 14
    • 80054908624 scopus 로고    scopus 로고
    • Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors
    • Matos MJ, et al,. Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors. J Med Chem 2011; 54: 7127-7137.
    • (2011) J Med Chem , vol.54 , pp. 7127-7137
    • Matos, M.J.1
  • 15
    • 79956100956 scopus 로고    scopus 로고
    • New halogenated phenylcoumarins as tyrosinase inhibitors
    • Matos MJ, et al,. New halogenated phenylcoumarins as tyrosinase inhibitors. Bioorg Med Chem Lett 2011; 21: 3342-3345.
    • (2011) Bioorg Med Chem Lett , vol.21 , pp. 3342-3345
    • Matos, M.J.1
  • 16
    • 84857253918 scopus 로고    scopus 로고
    • 3-Substituted coumarins as dual inhibitors of AChE and MAO for the treatment of Alzheimer's disease
    • Viña D, et al,. 3-Substituted coumarins as dual inhibitors of AChE and MAO for the treatment of Alzheimer's disease. MedChemComm 2011; 3: 213-218.
    • (2011) MedChemComm , vol.3 , pp. 213-218
    • Viña, D.1
  • 17
    • 84655170309 scopus 로고    scopus 로고
    • Hydroxycoumarins as selective MAO-B inhibitors
    • Serra S, et al,. Hydroxycoumarins as selective MAO-B inhibitors. Bioorg Med Chem Lett 2012; 22: 258-261.
    • (2012) Bioorg Med Chem Lett , vol.22 , pp. 258-261
    • Serra, S.1
  • 18
    • 64549137053 scopus 로고    scopus 로고
    • Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins
    • Chimenti F, et al,. Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7- substituted coumarins. J Med Chem 2009; 52: 1935-1942.
    • (2009) J Med Chem , vol.52 , pp. 1935-1942
    • Chimenti, F.1
  • 19
    • 0035209620 scopus 로고    scopus 로고
    • International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors
    • Fredholm BB, et al,. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharm Rev 2001; 53: 527-552.
    • (2001) Pharm Rev , vol.53 , pp. 527-552
    • Fredholm, B.B.1
  • 20
  • 21
    • 0034052190 scopus 로고    scopus 로고
    • A(3) adenosine receptor ligands: History and perspectives
    • Baraldi PG, et al,. A(3) adenosine receptor ligands: history and perspectives. Med Res Rev 2000; 20: 103-128.
    • (2000) Med Res Rev , vol.20 , pp. 103-128
    • Baraldi, P.G.1
  • 22
    • 53849085809 scopus 로고    scopus 로고
    • Adenosine receptors and asthma in humans
    • Wilson CN,. Adenosine receptors and asthma in humans. Br J Pharmacol 2008; 155: 475-486.
    • (2008) Br J Pharmacol , vol.155 , pp. 475-486
    • Wilson, C.N.1
  • 23
    • 38749132550 scopus 로고    scopus 로고
    • Adenosine receptor antagonists: Translating medicinal chemistry and pharmacology into clinical utility
    • Baraldi PG, et al,. Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility. Chem Rev 2008; 108: 238-263.
    • (2008) Chem Rev , vol.108 , pp. 238-263
    • Baraldi, P.G.1
  • 24
    • 64549143749 scopus 로고    scopus 로고
    • Novel 2- and 4-substituted 1H-imidazo[4,5-c]quinolin-4-amine derivatives as allosteric modulators of the A3 adenosine receptor
    • Kim Y, et al,. Novel 2- and 4-substituted 1H-imidazo[4,5-c]quinolin-4- amine derivatives as allosteric modulators of the A3 adenosine receptor. J Med Chem 2009; 52: 2098-2108.
    • (2009) J Med Chem , vol.52 , pp. 2098-2108
    • Kim, Y.1
  • 25
    • 79960579532 scopus 로고    scopus 로고
    • Synthesis of a new series of 1H-imidazol-1-yl substituted 8-phenylxanthines as adenosine receptor ligands
    • Bansal R, et al,. Synthesis of a new series of 1H-imidazol-1-yl substituted 8-phenylxanthines as adenosine receptor ligands. Chem Biol 2011; 8: 1290-1300.
    • (2011) Chem Biol , vol.8 , pp. 1290-1300
    • Bansal, R.1
  • 26
    • 80054972494 scopus 로고    scopus 로고
    • Affinity prediction on A3 adenosine receptor antagonists: The chemometric approach
    • Luan F, et al,. Affinity prediction on A3 adenosine receptor antagonists: the chemometric approach. Bioorg Med Chem 2011; 19: 6853-6859.
    • (2011) Bioorg Med Chem , vol.19 , pp. 6853-6859
    • Luan, F.1
  • 27
    • 36549081419 scopus 로고    scopus 로고
    • The A3 adenosine receptor: An enigmatic player in cell biology
    • Gessi S, et al,. The A3 adenosine receptor: an enigmatic player in cell biology. Pharmacol Ther 2008; 117: 123-140.
    • (2008) Pharmacol Ther , vol.117 , pp. 123-140
    • Gessi, S.1
  • 28
    • 23744481524 scopus 로고    scopus 로고
    • 1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells
    • 1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells. Biochem Pharmacol 2005; 70: 918-924.
    • (2005) Biochem Pharmacol , vol.70 , pp. 918-924
    • Lee, E.J.1
  • 29
    • 0030433659 scopus 로고    scopus 로고
    • In vivo role of the adenosine A3 receptor: N6-2-(4-aminophenyl) ethyladenosine induces bronchospasm in BDE rats by a neurally mediated mechanism involving cells resembling mast cells
    • Meade CJ, et al,. In vivo role of the adenosine A3 receptor: N6-2-(4-aminophenyl)ethyladenosine induces bronchospasm in BDE rats by a neurally mediated mechanism involving cells resembling mast cells. J Pharmacol Exp Ther 1996; 279: 1148-1156.
    • (1996) J Pharmacol Exp Ther , vol.279 , pp. 1148-1156
    • Meade, C.J.1
  • 30
    • 84860664996 scopus 로고    scopus 로고
    • 3 adenosine receptor ligands based on chromone scaffold
    • 3 adenosine receptor ligands based on chromone scaffold. Biochem Pharmacol 2012; 84: 21-29.
    • (2012) Biochem Pharmacol , vol.84 , pp. 21-29
    • Gaspar, A.1
  • 31
    • 80054893720 scopus 로고    scopus 로고
    • 3 da adenosina: Uma nova abordagem terapêutica no ĉncer
    • 3 da adenosina: uma nova abordagem terapêutica no ĉncer. Quim Nova 2011; 34: 1417-1424.
    • (2011) Quim Nova , vol.34 , pp. 1417-1424
    • Gaspar, A.1
  • 32
    • 84870870078 scopus 로고
    • Cumarindiol und Cumarin-Chromon-Tautomerie (Coumarindiol and coumarin-chromone tautomerism)
    • Fritz A, et al,. Cumarindiol und Cumarin-Chromon-Tautomerie (Coumarindiol and coumarin-chromone tautomerism). Chem Ber 1951; 84: 319-329.
    • (1951) Chem Ber , vol.84 , pp. 319-329
    • Fritz, A.1
  • 33
    • 0042586289 scopus 로고
    • 2,2-Dimethylchromene dimer. 2,2-Dimethylchromene and related compounds
    • Barnes CS, et al,. 2,2-Dimethylchromene dimer. 2,2-Dimethylchromene and related compounds. Tetrahedron 1963; 19: 839-847.
    • (1963) Tetrahedron , vol.19 , pp. 839-847
    • Barnes, C.S.1
  • 34
    • 3242775328 scopus 로고
    • Reaction of two oxazolo[4',5': 3,4]coumarins with alkali
    • Stammer CH,. Reaction of two oxazolo[4',5': 3,4]coumarins with alkali. J Org Chem 1960; 25: 460-461.
    • (1960) J Org Chem , vol.25 , pp. 460-461
    • Stammer, C.H.1
  • 35
    • 84857307624 scopus 로고
    • Some aminocoumarin derivatives possessing local anesthetic activity
    • Merchant JR, Martyres G,. Some aminocoumarin derivatives possessing local anesthetic activity. Curr Sci 1981; 50: 410-411.
    • (1981) Curr Sci , vol.50 , pp. 410-411
    • Merchant, J.R.1    Martyres, G.2
  • 36
    • 0031931065 scopus 로고    scopus 로고
    • Comparative pharmacology of human adenosine receptor subtypes - Characterization of stably transfected receptors in CHO cells
    • Klotz KN, et al,. Comparative pharmacology of human adenosine receptor subtypes-characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol 1997; 357: 1-9.
    • (1997) Naunyn Schmiedebergs Arch Pharmacol , vol.357 , pp. 1-9
    • Klotz, K.N.1
  • 37
    • 33846116634 scopus 로고    scopus 로고
    • [3H]HEMADO-a novel tritiated agonist selective for the human adenosine A3 receptor
    • Klotz KN, et al,. [3H]HEMADO-a novel tritiated agonist selective for the human adenosine A3 receptor. Eur J Pharmacol 2007; 556: 14-18.
    • (2007) Eur J Pharmacol , vol.556 , pp. 14-18
    • Klotz, K.N.1
  • 38
    • 0020084268 scopus 로고
    • Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes
    • De Lean A, et al,. Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol Pharmacol 1982; 21: 5-16.
    • (1982) Mol Pharmacol , vol.21 , pp. 5-16
    • De Lean, A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.